HLA-C and neoplasm: On the contrary, major limitations of such an approach are represented by the need of MHC prediction binding algorithms for the selection of immunogenic peptides, the heterogeneity of MHC restriction, the down regulation of MHC class I molecules in many tumor types and, most importantly, the limited immunogenicity of peptides.